Weich, A.; Werner, R.A.; Buck, A.K.; Hartrampf, P.E.; Serfling, S.E.; Scheurlen, M.; Wester, H.-J.; Meining, A.; Kircher, S.; Higuchi, T.;
et al. CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas. Diagnostics 2021, 11, 605.
https://doi.org/10.3390/diagnostics11040605
AMA Style
Weich A, Werner RA, Buck AK, Hartrampf PE, Serfling SE, Scheurlen M, Wester H-J, Meining A, Kircher S, Higuchi T,
et al. CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas. Diagnostics. 2021; 11(4):605.
https://doi.org/10.3390/diagnostics11040605
Chicago/Turabian Style
Weich, Alexander, Rudolf A. Werner, Andreas K. Buck, Philipp E. Hartrampf, Sebastian E. Serfling, Michael Scheurlen, Hans-Jürgen Wester, Alexander Meining, Stefan Kircher, Takahiro Higuchi,
and et al. 2021. "CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas" Diagnostics 11, no. 4: 605.
https://doi.org/10.3390/diagnostics11040605
APA Style
Weich, A., Werner, R. A., Buck, A. K., Hartrampf, P. E., Serfling, S. E., Scheurlen, M., Wester, H.-J., Meining, A., Kircher, S., Higuchi, T., Pomper, M. G., Rowe, S. P., Lapa, C., & Kircher, M.
(2021). CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas. Diagnostics, 11(4), 605.
https://doi.org/10.3390/diagnostics11040605